| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/23/2006 | US20060041953 Control of fruit dehiscence in Arabidopsis by indehiscenti genes |
| 02/23/2006 | US20060041952 P450 polynucleotides, polypeptides, and uses thereof |
| 02/23/2006 | US20060041951 detecting at least one allelic form of a polymorphic simple sequence repeat (SSR) or a single nucleotide polymorphism (SNP); genetic engineered plant display tolerance or improved tolerance to Phytophthora root rot infection; employing a polymerase chain reaction (PCR) or ligase chain reaction (LCR) |
| 02/23/2006 | US20060041950 Cassava vein mosaic virus promoters nucleic acid sequences and expression vectors |
| 02/23/2006 | US20060041949 Propagating transgenic plants with decreased nicotine demethylase activity; breeding tobacco with reduce concentrations of carcinogenic compounds |
| 02/23/2006 | US20060041948 Transgenic mice containing chemokine receptor 9A gene disruptions |
| 02/23/2006 | US20060041946 Nuclear transfer nuclei from histone hypomethylated donor cells |
| 02/23/2006 | US20060041945 Bovine with homozygous mutations of both alleles that lacks functional immunoglobulin M (IgM) heavy chain; reduced levels of endogenous IgM heavy chain and/or prion protein; use to alleviate risk or fear of bovine spongiform encephalopathy (mad cow disease) |
| 02/23/2006 | US20060041113 Phytase enzymes, nucleic acids encoding phytase enzymes and vectors and host cells incorporating same |
| 02/23/2006 | US20060041112 Novel human G-coupled protein receptor kinases and polynucleotides encoding the same |
| 02/23/2006 | US20060041107 Mutants of streptococcal toxin A and methods of use |
| 02/23/2006 | US20060040886 heat shock protein 27 inhibitors; RNA interference; nuclease resistance |
| 02/23/2006 | US20060040883 Methods for treating cancer using anti-Wnt2 monoclonal antibodies and siRNA |
| 02/23/2006 | US20060040882 Compostions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells |
| 02/23/2006 | US20060040881 Modulators of coagulation factors |
| 02/23/2006 | US20060040877 Capable of functioning in Saccharopolyspora spinosa; for controlling insects |
| 02/23/2006 | US20060040876 Modulation of peroxisome proliferator-activated receptors |
| 02/23/2006 | US20060040862 XAF genes and polypeptides: methods and reagents for modulating apoptosis |
| 02/23/2006 | US20060040859 Peptides, DNAs, RNAs, and compounds for inhibiting or inducing adrenomedullin activity, and use of the same |
| 02/23/2006 | US20060040411 Light-controlled electrokinetic assembly of particles near surfaces |
| 02/23/2006 | US20060040393 Controlled lysis of bacteria |
| 02/23/2006 | US20060040391 RNA interference vectors |
| 02/23/2006 | US20060040390 Device, method, system, and program for intelligent in vivo cell-level chemical or genetic material delivery |
| 02/23/2006 | US20060040387 Islet cells from human embryonic stem cells |
| 02/23/2006 | US20060040382 Tagged epitope protein transposable element |
| 02/23/2006 | US20060040373 Papermaking, food, agriculture; genetic engineered polynucleotide; degradation of plant cell wall components; decomposition of plants and fruits |
| 02/23/2006 | US20060040372 GANP protein |
| 02/23/2006 | US20060040371 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 02/23/2006 | US20060040370 Purified thermostable pyrococcus furiosus dna polymerase i |
| 02/23/2006 | US20060040364 DNA coding for a protein which imparts L-homoserine resistance to Escherichia coli bacterium, and a method for producing L-amino acids |
| 02/23/2006 | US20060040363 Human antibodies derived from immunized xenomice |
| 02/23/2006 | US20060040362 Recombinant human Mannan-Building Proteins |
| 02/23/2006 | US20060040360 Adipocyte complement related protein homolog zacrp7 |
| 02/23/2006 | US20060040358 IGF-1 receptor interacting proteins |
| 02/23/2006 | US20060040356 Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins |
| 02/23/2006 | US20060040355 Mutated Tn5 transposase proteins and the use thereof |
| 02/23/2006 | US20060040353 Production of galactosylated glycoproteins in lower eukaryotes |
| 02/23/2006 | US20060040351 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/23/2006 | US20060040347 Use of triplex structure DNA in transferring nucleotide sequences |
| 02/23/2006 | US20060040346 Bacterial bioreactor for propagation of enzymatic polypeptides |
| 02/23/2006 | US20060040343 Identification of 3-Ketosteroid 9-Alfa-hydroxylase genes and microorganisms blocked in 3-Ketosteroid 9-Alfa-hydroxylase activity |
| 02/23/2006 | US20060040342 sequences that regulate the expression of genes that are differentially expressed in a native fungus exhibiting a pelleted morphology relative to a filamented morphology |
| 02/23/2006 | US20060040336 Containing an acetylated substrate peptide labeled with a substance which emits a signal; and a peptidase whose peptide-cleaving activity changes upon an acetylation level of the substrate peptide. |
| 02/23/2006 | US20060040313 Human chemokine beta-9 |
| 02/23/2006 | US20060040307 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents |
| 02/23/2006 | US20060040306 81588 methods and compositions of human proteins and uses thereof |
| 02/23/2006 | US20060040297 Methods of amplifying and sequencing nucleic acids |
| 02/23/2006 | US20060040296 Determining in a sample from the diabetic patient presence of a polypeptide comprising (Thrombin-Activable Fibrinolysis Inhibitor, TAFI); stroke, transitory ischemic attack, atherosclerotic cerebrovascular disease and/or coronary heart disease; cardiovascular disorders |
| 02/23/2006 | US20060040294 Cleavage of nucleic acids |
| 02/23/2006 | US20060040282 Oligonucleotide sizing using cleavable primers |
| 02/23/2006 | US20060040281 Polyhydroxybutyrate polymerase |
| 02/23/2006 | US20060040279 DNA chips used for bioprocess control |
| 02/23/2006 | US20060040278 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer |
| 02/23/2006 | US20060040277 Nucleic sequences encoding an AT2 receptor-interacting protein (ATIP) and their applications |
| 02/23/2006 | US20060040272 Composition comprising library of double stranded nucleic acids |
| 02/23/2006 | US20060040271 Processes for detecting or quantifying more than one nucleic acid in a library |
| 02/23/2006 | US20060040270 Processes for detecting or quantifying more than one nucleic acid in library |
| 02/23/2006 | US20060040267 Transcriptional activator |
| 02/23/2006 | US20060040266 Diagnostics and therapeutics for diseases associated with neuromedin u2 receptor (nmu2) |
| 02/23/2006 | US20060040265 Regulation of novel human asparagine-hydroxylases |
| 02/23/2006 | US20060040264 Means for identifying neisseria meningitidis-specific genes |
| 02/23/2006 | US20060040262 Novel compositions and methods in cancer |
| 02/23/2006 | US20060040261 Primers for isothermal amplification of hepatitis C virus |
| 02/23/2006 | US20060040255 Cell line designated KT-1 established from tongue epithelial and use thereof |
| 02/23/2006 | US20060040250 G-protein coupled receptor fusion protein is modified to include one or more sets of serine/threonine clusters, which enhance binding of such GPCR to arrestin; screening for GPCR ligands, agonists and/or antagonists |
| 02/23/2006 | US20060039928 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 02/23/2006 | US20060039925 Mutants of streptococcal toxin a and methods of use |
| 02/23/2006 | US20060039922 Streptococcal heat shock proteins of the Hsp60 family |
| 02/23/2006 | US20060039920 Immunization, scrub typhus of tsutsugamushi disease, HIV |
| 02/23/2006 | US20060039918 Stress proteins and peptides and methods of use thereof |
| 02/23/2006 | US20060039915 P-cadherin as a target for anti-cancer therapy |
| 02/23/2006 | US20060039909 Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes |
| 02/23/2006 | US20060039906 Humanized antibodies that sequester abeta peptide |
| 02/23/2006 | US20060039897 transforming a stinging cell or stinging cell progenitor with a polynucleotide encoding a therapeutic, cosmetic or diagnostic agent to thereby generate at least one stinging cell expressing therapeutic, cosmetic or diagnostic agent in the stinging cell (derived from Cnidaria, Dinoflagelleaa) |
| 02/23/2006 | US20060039893 Expression vector includes insert of dna which codes for exogenous protein and adenovirus dna having deletion from nucleotides 356-4020; production of recombinant proteins; gene therapy against tumors and cancer |
| 02/23/2006 | US20060039884 Baldness related gene and the polypeptide encoded thereby , and uses |
| 02/23/2006 | US20060039860 Delivering a biopolymer to a cell by forming a complex of a biologically active polymer and a cyclic amidinium-containing compound and associating the complex with the cell |
| 02/23/2006 | DE20023745U1 Method of modulating expression of an endogenous cellular gene in a cell to prevent gene activation or prevent repression of gene expression comprising contacting a target sequence with a zinc finger protein |
| 02/23/2006 | DE10335447B4 Aminooxidase Amino oxidase |
| 02/23/2006 | DE102004040134A1 Neue essentielle Gene von Bacillus licheniformis und darauf aufbauende verbesserte biotechnologische Produktionsverfahren New essential genes from Bacillus licheniformis, upon which improved biotechnological production |
| 02/23/2006 | DE102004038535A1 Zelluläre Einschleusung von Nukleinsäurewirkstoffen Cellular introduction of nucleic acid drugs |
| 02/23/2006 | DE102004037652A1 Process to modify nucleic acid for incorporation in a vectored expression in e.g. transgenic animals, medical therapy or vaccines |
| 02/23/2006 | CA2779559A1 Variant fc regions |
| 02/23/2006 | CA2592521A1 Modified vitamin k dependent polypeptides |
| 02/23/2006 | CA2579764A1 Methods of regulating differentiation and treating of multiple myeloma |
| 02/23/2006 | CA2577250A1 Cytochrome p450 induction assay |
| 02/23/2006 | CA2577213A1 Use of gsk-3 inhibitors for the treatment of prostate cancer |
| 02/23/2006 | CA2577036A1 Small interfering rna molecules against ribonucleotide reductase and uses thereof |
| 02/23/2006 | CA2576860A1 Methods for modulating lipoprotein and cholesterol levels in human |
| 02/23/2006 | CA2576296A1 Nucleic acids conferring lipid and sugar alterations in plants ii |
| 02/23/2006 | CA2576277A1 Plants having improved growth characteristics and method for making the same |
| 02/23/2006 | CA2576083A1 Protein production method utilizing yebf |
| 02/23/2006 | CA2575658A1 Selection |
| 02/23/2006 | CA2575163A1 Adenoviral vector compositions |
| 02/23/2006 | CA2574098A1 Retinal dystrophin transgene and methods of use thereof |
| 02/23/2006 | CA2573671A1 Methods for reducing or preventing localized fibrosis using sirna |
| 02/23/2006 | CA2573440A1 Inhibition of biofilm formation |
| 02/23/2006 | CA2573192A1 Variant fc regions |
| 02/23/2006 | CA2571942A1 Compositions and methods of purifying myelin-associated glycoprotein (mag) |
| 02/23/2006 | CA2569235A1 Anti-ghrelin antibodies |